SURGICAL PREVENTION AND TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM IN PATIENTS OPERATED ON THYROID GLAND

Georgian Med News. 2018 Mar:(276):34-40.

Abstract

The objective of the research was to develop and evaluate the algorithm of prevention and treatment of postoperative hypoparathyroidism (PHPT) based on determining parathyroid glands (PTG) viability and the use of antihypoxant-antioxidant therapy in the postoperative period. The research was based on the results of a comprehensive examination and treatment of 60 patients who were operated for thyroid gland diseases. The patients underwent inpatient treatment at the surgical department of Ivano-Frankivsk Central City Clinical Hospital and Ivano-Frankivsk Regional Oncology Center from 2015 to 2017. We proposed an algorithm for surgical prevention and treatment of PHPT during thyroid gland surgeries which consisted in the following. We performed a visual assessment of PTG intraoperatively and evaluated each gland from 0 to 3 points according to the degree of its viability affection. If the gland was evaluated at 0-2 points, we left it in situ, since there was a high probability of maintaining its function. If it was evaluated at 3 points, its autotransplantation was performed. Cytoflavin drug was applied in a dose of 10 ml per 200 0.9% NaCl intravenously once a day during 7 days in the postoperative period for the purpose of antihypoxant-antioxidant therapy. 2 groups of patients were formed in order to evaluate the effectiveness of the algorithm. Each group consisted of 30 people. Patients of Group I underwent surgery on thyroid gland according to generally accepted rules. Patients of Group II underwent interventions according to the above-mentioned algorithm. The use of our proposed algorithm (intraoperative assessment of PTG viability and antihypoxant-antioxidant therapy in the postoperative period) significantly reduces the frequency of permanent PHPT justifying indications to its application.

MeSH terms

  • Antioxidants / therapeutic use
  • Drug Combinations
  • Flavin Mononucleotide / therapeutic use
  • Humans
  • Hypoparathyroidism / etiology
  • Hypoparathyroidism / physiopathology
  • Hypoparathyroidism / prevention & control
  • Hypoparathyroidism / therapy*
  • Hypoxia / drug therapy
  • Inosine Diphosphate / therapeutic use
  • Middle Aged
  • Niacinamide / therapeutic use
  • Parathyroid Glands / physiopathology
  • Postoperative Complications / physiopathology
  • Postoperative Complications / prevention & control
  • Postoperative Complications / therapy*
  • Succinates / therapeutic use
  • Thyroid Diseases / surgery*

Substances

  • Antioxidants
  • Drug Combinations
  • Succinates
  • cytoflavin
  • Niacinamide
  • Flavin Mononucleotide
  • Inosine Diphosphate